ES2151908T3 - Derivados del acido fenil-ciclohexano-carboxilico sustituidos con heterociclo. - Google Patents

Derivados del acido fenil-ciclohexano-carboxilico sustituidos con heterociclo.

Info

Publication number
ES2151908T3
ES2151908T3 ES94101543T ES94101543T ES2151908T3 ES 2151908 T3 ES2151908 T3 ES 2151908T3 ES 94101543 T ES94101543 T ES 94101543T ES 94101543 T ES94101543 T ES 94101543T ES 2151908 T3 ES2151908 T3 ES 2151908T3
Authority
ES
Spain
Prior art keywords
derivatives
cyclhexan
heterociclo
phenyl
acid substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94101543T
Other languages
English (en)
Spanish (es)
Inventor
Ulrich E Dr Muller
Jurgen Dr Dressel
Peter Dr Fey
Rudolf H Dr Hanko
Walter Dr Hubsch
Thomas Dr Kramer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2151908T3 publication Critical patent/ES2151908T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES94101543T 1993-02-15 1994-02-02 Derivados del acido fenil-ciclohexano-carboxilico sustituidos con heterociclo. Expired - Lifetime ES2151908T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4304455A DE4304455A1 (de) 1993-02-15 1993-02-15 Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate

Publications (1)

Publication Number Publication Date
ES2151908T3 true ES2151908T3 (es) 2001-01-16

Family

ID=6480447

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94101543T Expired - Lifetime ES2151908T3 (es) 1993-02-15 1994-02-02 Derivados del acido fenil-ciclohexano-carboxilico sustituidos con heterociclo.

Country Status (25)

Country Link
US (1) US5395840A (cg-RX-API-DMAC7.html)
EP (1) EP0611767B1 (cg-RX-API-DMAC7.html)
JP (1) JPH06293741A (cg-RX-API-DMAC7.html)
KR (1) KR940019708A (cg-RX-API-DMAC7.html)
CN (1) CN1057085C (cg-RX-API-DMAC7.html)
AT (1) ATE196141T1 (cg-RX-API-DMAC7.html)
AU (1) AU672262B2 (cg-RX-API-DMAC7.html)
CA (1) CA2115536C (cg-RX-API-DMAC7.html)
CZ (1) CZ289096B6 (cg-RX-API-DMAC7.html)
DE (2) DE4304455A1 (cg-RX-API-DMAC7.html)
DK (1) DK0611767T3 (cg-RX-API-DMAC7.html)
ES (1) ES2151908T3 (cg-RX-API-DMAC7.html)
FI (1) FI106716B (cg-RX-API-DMAC7.html)
GR (1) GR3034957T3 (cg-RX-API-DMAC7.html)
IL (1) IL108625A (cg-RX-API-DMAC7.html)
MY (1) MY131595A (cg-RX-API-DMAC7.html)
NO (1) NO300810B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ250864A (cg-RX-API-DMAC7.html)
PH (1) PH30172A (cg-RX-API-DMAC7.html)
PL (1) PL177834B1 (cg-RX-API-DMAC7.html)
PT (1) PT611767E (cg-RX-API-DMAC7.html)
RU (1) RU2119480C1 (cg-RX-API-DMAC7.html)
SK (1) SK15294A3 (cg-RX-API-DMAC7.html)
UA (1) UA35574C2 (cg-RX-API-DMAC7.html)
ZA (1) ZA94984B (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW300219B (cg-RX-API-DMAC7.html) * 1991-09-14 1997-03-11 Hoechst Ag
DE19503160A1 (de) * 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden
HRP960015B1 (en) * 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
AU746706B2 (en) 1997-07-03 2002-05-02 Du Pont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
JP2002529537A (ja) * 1998-11-17 2002-09-10 ビーエーエスエフ アクチェンゲゼルシャフト 2−フェニルベンズイミダゾールおよび2−フェニルインドール、その製造方法ならびに使用
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
DE10044792A1 (de) 2000-09-11 2002-04-04 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung
KR101415348B1 (ko) 2006-05-09 2014-07-04 미츠비시 가스 가가쿠 가부시키가이샤 4-(4-알킬시클로헥실)벤즈알데히드
KR101903354B1 (ko) 2009-06-17 2018-10-04 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
KR20140014110A (ko) 2010-12-16 2014-02-05 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
PH12013502611A1 (en) 2011-06-24 2014-04-28 Amgen Inc Trpm8 antagonists and their use in treatments
CA2839703A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
BR112014032913A2 (pt) 2012-06-29 2017-06-27 Pfizer novas 4-(amino-substituídas)-7h-pirrolo[2,3-d]pirimidinas como inibidores de lrrk2
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
LT3421468T (lt) 2013-11-13 2021-01-11 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitorių paruošimo būdai
HRP20191525T1 (hr) 2013-11-13 2019-11-29 Vertex Pharma Inhibitori replikacije virusa influence
JP6487921B2 (ja) 2013-12-17 2019-03-20 ファイザー・インク LRRK2阻害薬としての新規の3,4−二置換−1H−ピロロ[2,3−b]ピリジンおよび4,5−二置換−7H−ピロロ[2,3−c]ピリダジン
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
AU2016322813B2 (en) 2015-09-14 2021-04-01 Pfizer Inc. Novel imidazo (4,5-c) quinoline and imidazo (4,5-c)(1,5) naphthyridine derivatives as LRRK2 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
ES2121773T3 (es) * 1990-06-08 1998-12-16 Hoechst Marion Roussel Inc Derivados de bencimidazol, su procedimiento de preparacion, productos intermedios, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
EP0470543A1 (de) * 1990-08-10 1992-02-12 Dr. Karl Thomae GmbH Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
DE4031635A1 (de) * 1990-10-05 1992-04-09 Thomae Gmbh Dr K Substituierte 1-benzyl-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate

Also Published As

Publication number Publication date
CA2115536C (en) 2004-11-02
FI940659A7 (fi) 1994-08-16
UA35574C2 (uk) 2001-04-16
PL177834B1 (pl) 2000-01-31
NO300810B1 (no) 1997-07-28
GR3034957T3 (en) 2001-02-28
EP0611767B1 (de) 2000-09-06
FI940659A0 (fi) 1994-02-11
DK0611767T3 (da) 2001-01-02
DE59409509D1 (de) 2000-10-12
ATE196141T1 (de) 2000-09-15
JPH06293741A (ja) 1994-10-21
EP0611767A1 (de) 1994-08-24
KR940019708A (ko) 1994-09-14
DE4304455A1 (de) 1994-08-18
PH30172A (en) 1997-01-21
PT611767E (pt) 2001-02-28
IL108625A (en) 1997-09-30
AU672262B2 (en) 1996-09-26
ZA94984B (en) 1994-08-24
CZ289096B6 (cs) 2001-11-14
MY131595A (en) 2007-08-30
CN1057085C (zh) 2000-10-04
AU5480794A (en) 1994-08-18
US5395840A (en) 1995-03-07
PL302213A1 (en) 1994-08-22
NO940506D0 (no) 1994-02-14
CN1108257A (zh) 1995-09-13
NO940506L (cg-RX-API-DMAC7.html) 1994-08-16
SK15294A3 (en) 1994-12-07
CZ32994A3 (en) 1994-08-17
IL108625A0 (en) 1994-05-30
NZ250864A (en) 1995-03-28
RU2119480C1 (ru) 1998-09-27
FI106716B (fi) 2001-03-30
CA2115536A1 (en) 1994-08-16

Similar Documents

Publication Publication Date Title
ES2151908T3 (es) Derivados del acido fenil-ciclohexano-carboxilico sustituidos con heterociclo.
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ES2056854T3 (es) Tiadiazinonas.
DE3171620D1 (en) A dried, sterilized, gamma-globulin-fixed column and a process for preparing the same
ES8201596A1 (es) Procedimiento de obtencion de mucopolisacaridos
ATE77557T1 (de) Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
ES2007607A6 (es) Un procedimiento para la obtencion de un preparado de insulina para la administracion no parenteral.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2040231T3 (es) Composiciones medicamentosas estables.
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
DK0421541T3 (da) Tabletstruktur, som kan deles
ATE65696T1 (de) Verwendung von defibrotid bei der behandlung von zustaenden akuter nierenschwaeche.
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
ES2103847T3 (es) Azadecalinas amidas y tiamidas como inhibidores de la biosintesis del colesterol.
ES2109412T3 (es) (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento.
MX9302487A (es) Piridonas sustituidas por bifenilmetilo, procedimiento para su obtencion y medicamentos que las contienen.
ES8700232A1 (es) Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol
ES2119165T3 (es) Nueva actividad de cofactor anticoagulante.
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
ES2080848T3 (es) Un nuevo retinoide, su obtencion y utilizacion en medicamentos.
ES2058343T3 (es) Piridinas disubstituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 611767

Country of ref document: ES